Gnosco

Name

Gnosco

Legal name

Omda Dermicus AB

Website

https://gnosco.se

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Telemedicine Software

akta.pro primary industry

Dermatology Telemedicine Platforms (HLALAGAA)

Keywords

• Teledermatology platform
• Telewound care software
• Clinical image management
• Dermatology diagnostics
• EMR integration software

Headquarters

HQ city

Göteborg

HQ country

Sweden

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

1. Healthcare SaaS Platform Subscription: Dermicus operates as a SaaS healthcare platform offering teledermatology and telewound care solutions to healthcare providers on a subscription basis, enabling secure collaboration and remote diagnostics.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Gnosco (operating through its subsidiary Omda Dermicus AB) develops and sells the Dermicus platform, a purpose-built teledermatology and telewound care SaaS solution. The platform enables healthcare providers to capture clinical images via mobile workflows, run AI-enabled image quality checks, and collaborate securely with specialist dermatologists across primary and secondary care settings. Open APIs allow integration with local hospital systems and Electronic Medical Records (EMRs).

Product overview

Gnosco (operated as Dermicus by Omda Dermicus AB) offers a unified platform-plus-modules architecture centered on the Dermicus Platform. The core portfolio includes Dermicus Telederm for teledermatology and Dermicus Telewound for wound management, both powered by AI-enabled image quality checks. Supporting modules include reference markers for wound measurement and an online education course. All solutions share common infrastructure including open APIs for EMR connectivity, mobile image capture workflows, and specialist remote diagnostic capabilities.

Differentiator

Problem solved

Functional benefit

Brands

• Dermicus Telederm: Purpose-built teledermatology application for efficient patient management and secure collaboration for multi-disciplinary teams across primary and secondary care
• Dermicus Telewound

Products and services

• Dermicus Telederm

Quantifiable outcome

• Reduces waiting times for dermatology consultations
• +2 more outcomes

Named customers2 records

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• EMR/Hospital System IntegrationscoreTechnology or IntegrationDermicus integrates with local hospital systems and Electronic Medical Records (EMRs) through open APIs, enabling seamless data exchange within existing healthcare IT infrastructure across primary and secondary care settings.
• UK NHS Healthcare SystemcoreOthersDermicus operates within the UK NHS healthcare ecosystem with compliance to NHS DTAC and clinical safety standards, serving NHS trusts and UK healthcare providers with teledermatology and telewound solutions.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• Skin Analytics: UK-based AI dermatology company providing teledermatology and AI-powered skin cancer triage to NHS trusts. Directly comparable as a UK-anchored, AI-enabled teledermatology platform pursuing the same NHS procurement channel.
• SkinVision: Amsterdam-based AI skin assessment app offering smartphone-based skin lesion analysis and teledermatology connections. Comparable as a European teledermatology/AI dermatology platform with regulated medical device positioning and multi-geography footprint.
• MetaOptima Technology: Developer of DermEngine, an AI-powered dermatology imaging and teledermatology platform used by clinics and teledermatology services worldwide. Comparable as a teledermatology imaging platform with AI image analysis capabilities and EMR integration focus.
• First Derm: Teledermatology platform connecting patients and primary care providers to dermatologists via image-based consultations. Comparable as a direct-to-provider teledermatology service operating in European markets with a focus on asynchronous specialist review.
• MedX Health Corp: Teledermatology and AI skin assessment platform providing image capture devices and remote specialist review for skin cancer screening. Comparable as an image-based teledermatology solution with regulated medical device status and pharmacy/clinical channel partnerships.
• MoleMap: Skin cancer screening and teledermatology service combining in-person imaging with specialist dermatologist review. Comparable as a skin-cancer-focused service using image capture and remote specialist diagnostics, though with a stronger in-person component.

Emerging players

• Klara: Telemedicine platform with specialty care offerings including dermatology consults for providers and patients. Comparable as a multi-specialty telehealth platform with dermatology workflows, though broader than Dermicus's dermatology-only focus.
• iDoc24: Teledermatology consultation service offering dermatologist review of skin images submitted by users and clinicians. Comparable as an image-based dermatology specialist consultation service, though smaller scale and primarily consumer-direct.
• 3Derm Systems: Teledermatology platform using standardized skin imaging and remote specialist review for primary care referrals. Comparable as a teledermatology workflow tool focused on primary care-to-specialist referral efficiency, similar to Dermicus's core use case.

Broad incumbents

• Omda (formerly known as Norway Health Tech / DIPS): Nordic-based health technology company providing electronic patient record and specialized healthcare software including dermatology modules. Comparable because Gnosco's Dermicus is owned by Omda Dermicus AB, suggesting an Omda connection, and as a broader Nordic healthcare IT incumbent with adjacent dermatology capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

• Facebookfacebook.com/gnosco
• LinkedInlinkedin.com/company/gnosco

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gnosco